Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 9, 2011, Pages 1190-1199

  Wang, Zhi Qiang ^a,b   Tao, Ya Xiong ^b  

^a YANGZHOU UNIVERSITY   (China)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Binding; Intracellular retention; Melanocortin 4 receptor; Naturally occurring mutation; Signaling

Indexed keywords

BETA INTERMEDIN; CYCLIC AMP; MELANOCORTIN 4 RECEPTOR;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; LIGAND BINDING; MUTAGENESIS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ALPHA-MSH; AMINO ACID SEQUENCE; BETA-MSH; CYCLIC AMP; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTOR, MELANOCORTIN, TYPE 4; SIGNAL TRANSDUCTION; TRANSFECTION;

MAMMALIA;

EID: 79960557425     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.06.008     Document Type: Article

References (47)

1. Gantz I., Fong T.M. The melanocortin system. Am. J. Physiol. 2003, 284:E468-E474.
2. Tao Y.X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr. Rev. 2010, 31:506-543.
3. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 1994, 8:1298-1308.
4. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
5. Yaswen L., Diehl N., Brennan M.B., Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 1999, 5:1066-1070.
6. Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I., Barsh G.S. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278:135-138.
7. Graham M., Shutter J.R., Sarmiento U., Sarosi I., Stark K.L. Overexpression of Agrt leads to obesity in transgenic mice. Nat. Genet. 1997, 17:273-274.
8. Cone R.D. Studies on the physiological functions of the melanocortin system. Endocr. Rev. 2006, 27:736-749.
9. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 1998, 20:111-112.
10. Vaisse C., Clement K., Guy-Grand B., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 1998, 20:113-114.
11. Farooqi I.S., Keogh J.M., Yeo G.S., Lank E.J., Cheetham T., O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 2003, 348:1085-1095.
12. Tao Y.X. Chapter 6 mutations in melanocortin-4 receptor and human obesity. Prog. Mol. Biol. Transl. Sci. 2009, 88:173-204.
13. Farooqi I.S., Yeo G.S., O'Rahilly S. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N. Engl. J. Med. 2003, 349:606-609. (author reply 606-609).
14. Tao Y.X., Segaloff D.L. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 2003, 144:4544-4551.
15. Tao Y.X. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol. Cell. Endocrinol. 2005, 239:1-14.
16. Wangensteen T., Pollestad Kolsgaard M.L., Mattingsdal M., Joner G., Tonstad S., Undlien D., Retterstol L. Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway. Exp. Clin. Endocrinol. Diabetes 2009, 117:266-273.
17. Stutzmann F., Tan K., Vatin V., Dina C., Jouret B., Tichet J., Balkau B., Potoczna N., Horber F., O'Rahilly S., Farooqi I.S., Froguel P., Meyre D. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 2008, 57:2511-2518.
18. Beckers S., Zegers D., de Freitas F., Peeters A.V., Verhulst S.L., Massa G., Van Gaal L.F., Timmermans J.P., Desager K.N., Van Hul W. Identification and functional characterization of novel mutations in the melanocortin-4 receptor. Obes. Facts 2010, 3:304-311.
19. Meehan T.P., Tabeta K., Du X., Woodward L.S., Firozi K., Beutler B., Justice M.J. Point mutations in the melanocortin-4 receptor cause variable obesity in mice. Mamm. Genome 2006, 17:1162-1171.
20. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 1987, 7:2745-2752.
21. Donohoue P.A., Tao Y.X., Collins M., Yeo G.S.H., O'Rahilly S., Segaloff D.L. Deletion of codons 88-92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female. J. Clin. Endocrinol. Metab. 2003, 88:5841-5845.
22. Tansky M.F., Pothoulakis C., Leeman S.E. Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10691-10696.
23. Fan Z.C., Sartin J.L., Tao Y.X. Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor. J. Endocrinol. 2008, 196:139-148.
24. Wang S.X., Fan Z.C., Tao Y.X. Functions of acidic transmembrane residues in human melanocortin-3 receptor binding and activation. Biochem. Pharmacol. 2008, 76:520-530.
25. Fan Z.C., Tao Y.X. Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients. J. Cell. Mol. Med. 2009, 13:3268-3282.
26. Lee Y.S., Challis B.G., Thompson D.A., Yeo G.S., Keogh J.M., Madonna M.E., Wraight V., Sims M., Vatin V., Meyre D., Shield J., Burren C., Ibrahim Z., Cheetham T., Swift P., Blackwood A., Hung C.C., Wareham N.J., Froguel P., Millhauser G.L., O'Rahilly S., Farooqi I.S. A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006, 3:135-140.
27. Biebermann H., Castaneda T.R., van Landeghem F., von Deimling A., Escher F., Brabant G., Hebebrand J., Hinney A., Tschop M.H., Gruters A., Krude H. A role for β-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 2006, 3:141-146.
28. Srinivasan S., Lubrano-Berthelier C., Govaerts C., Picard F., Santiago P., Conklin B.R., Vaisse C. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J. Clin. Invest. 2004, 114:1158-1164.
29. Granell S., Mohammad S., Ramanagoudr-Bhojappa R., Baldini G. Obesity-linked variants of melanocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell surface by a chemical chaperone. Mol. Endocrinol. 2010, 24:1805-1821.
30. Rene P., Le Gouill C., Pogozheva I.D., Lee G., Mosberg H.I., Farooqi I.S., Valenzano K.J., Bouvier M. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity. J. Pharmacol. Exp. Ther. 2010, 335:520-532.
31. Yang Y.K., Fong T.M., Dickinson C.J., Mao C., Li J.Y., Tota M.R., Mosley R., Van Der Ploeg L.H., Gantz I. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 2000, 39:14900-14911.
32. Fleck B.A., Chen C., Yang W., Huntley R., Markison S., Nickolls S.A., Foster A.C., Hoare S.R. Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor. Biochemistry 2005, 44:14494-14508.
33. Nargund R.P., Strack A.M., Fong T.M. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity. J. Med. Chem. 2006, 49:4035-4043.
34. Chen M., Aprahamian C.J., Celik A., Georgeson K.E., Garvey W.T., Harmon C.M., Yang Y. Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction. Biochemistry 2006, 45:1128-1137.
35. Yeo G.S., Lank E.J., Farooqi I.S., Keogh J., Challis B.G., O'Rahilly S. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum. Mol. Genet. 2003, 12:561-574.
36. Tao Y.X., Segaloff D.L. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. J. Clin. Endocrinol. Metab. 2005, 90:5632-5638.
37. Tao Y.X., Huang H., Wang Z.Q., Yang F., Williams J.N., Nikiforovich G.V. Constitutive activity of neural melanocortin receptors. Methods Enzymol. 2010, 484:267-279.
38. Tao Y.X. Constitutive activation of G protein-coupled receptors and diseases: insights into mechanism of activation and therapeutics. Pharmacol. Ther. 2008, 120:129-148.
39. Vaisse C., Clement K., Durand E., Hercberg S., Guy-Grand B., Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 2000, 106:253-262.
40. Lubrano-Berthelier C., Durand E., Dubern B., Shapiro A., Dazin P., Weill J., Ferron C., Froguel P., Vaisse C. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum. Mol. Genet. 2003, 12:145-153.
41. Nijenhuis W.A., Garner K.M., VanRozen R.J., Adan R.A. Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J. Biol. Chem. 2003, 278:22939-22945.
42. Tao Y.X. Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol. Ther. 2006, 111:949-973.
43. Mohammad S., Baldini G., Granell S., Narducci P., Martelli A.M., Baldini G. Constitutive traffic of melanocortin-4 receptor in neuro2A cells and immortalized hypothalamic neurons. J. Biol. Chem. 2007, 282:4963-4974.
44. Persani L., Lania A., Alberti L., Romoli R., Mantovani G., Filetti S., Spada A., Conti M. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J. Clin. Endocrinol. Metab. 2000, 85:2872-2878.
45. Shinozaki H., Butnev V., Tao Y.X., Ang K.L., Conti M., Segaloff D.L. Desensitization of Gs-coupled receptor signaling by constitutively active mutants of the human lutropin/choriogonadotropin receptor. J. Clin. Endocrinol. Metab. 2003, 88:1194-1204.
46. Tao Y.X. Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim. Biophys. Acta 2007, 1772:1167-1174.
47. Mencarelli M., Walker G.E., Maestrini S., Alberti L., Verti B., Brunani A., Petroni M.L., Tagliaferri M., Liuzzi A., Di Blasio A.M. Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur. J. Hum. Genet. 2008, 16:581-586.